13F

Stock

Fate Therapeutics Inc

FATE · held by 2 managers

Reported value

$2.81M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$82.2K

Price effect on 1 books still in the name

Largest holder

$2.66M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC263.9K$2.66MHeld
Leonteq Securities AG14.2K$143.6K−$82.2KCut−$5.98K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.